CARDLYTICS INC DL-,0001CARDLYTICS INC DL-,0001CARDLYTICS INC DL-,0001

CARDLYTICS INC DL-,0001

No trades
See on Supercharts
Market capitalization
‪521.04 M‬EUR
−3.130EUR
‪−122.04 M‬EUR
‪280.14 M‬EUR
‪41.10 M‬
Beta (1Y)
2.93

About CARDLYTICS INC DL-,0001

CEO
Karim Temsamani
Headquarters
Atlanta
Employees (FY)
434
Founded
2008
FIGI
BBG00K8FJXY3
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on DUS exchange CARDLYTICS INC DL-,0001 stocks are traded under the ticker CYX.
CARDLYTICS INC DL-,0001 is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
CYX earnings for the last quarter are −0.60 EUR per share, whereas the estimation was −0.61 EUR resulting in a 3.08% surprise. The estimated earnings for the next quarter are −0.21 EUR per share. See more details about CARDLYTICS INC DL-,0001 earnings.
CARDLYTICS INC DL-,0001 revenue for the last quarter amounts to ‪74.74 M‬ EUR despite the estimated figure of ‪75.73 M‬ EUR. In the next quarter revenue is expected to reach ‪81.13 M‬ EUR.
Yes, you can track CARDLYTICS INC DL-,0001 financials in yearly and quarterly reports right on TradingView.
CYX net income for the last quarter is ‪−91.36 M‬ EUR, while the quarter before that showed ‪−22.67 M‬ EUR of net income which accounts for −302.97% change. Track more CARDLYTICS INC DL-,0001 financial stats to get the full picture.
No, CYX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARDLYTICS INC DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.
CYX reached its all-time high on Jul 26, 2021 with the price of 112.000 EUR, and its all-time low was 2.372 EUR and was reached on Mar 29, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 434.00 employees. See our rating of the largest employees — is CARDLYTICS INC DL-,0001 on this list?
We've gathered analysts' opinions on CARDLYTICS INC DL-,0001 future price: according to them, CYX price has a max estimate of 16.58 EUR and a min estimate of 15.65 EUR. Read a more detailed CARDLYTICS INC DL-,0001 forecast: see what analysts think of CARDLYTICS INC DL-,0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARDLYTICS INC DL-,0001 EBITDA is ‪−31.82 M‬ EUR, and current EBITDA margin is −11.05%. See more stats in CARDLYTICS INC DL-,0001 financial statements.